Abstract:Background. Decisional conflict is defined as personal uncertainty about which course of action to take when choice among competing options involves risk, regret, or challenge to personal life values. It is influenced by inadequate knowledge, unclear values, inadequate support, and the perception that an ineffective decision has been made. Until recently, it has been studied at the individual level, which ignores the interpersonal system between patients and physicians. Objective. To explore the effect of feeling uninformed, unclear values, inadequate support, and the perception that an ineffective decision has been made on one own's outcome (actor effect) and on the other person's outcome (partner effect). Methods. After a clinical encounter, modifiable deficits and personal uncertainty were measured in physicians and patients using the Decisional Conflict Scale. Structural equation modeling was used to measure the parameters of the Actor-Partner Interdependence Model. Results. A total of 112 dyads of physicians and patients were included in the analysis. For both patients and physicians, 2 actor effects, unclear values (P < 0:0001) and the perception that an ineffective decision has been made (P < 0:0001), were found to be positively correlated with personal uncertainty. One partner effect, feeling uninformed (P=0:03), was found to be negatively correlated with personal uncertainty. Conclusions. Personal uncertainty of patients and physicians is influenced not only by their respective deficits but also by the deficits of the other member of the dyad. Our results indicate that the more unclear the expression of their own values and the more they perceive that an ineffective choice had been made, the more both physicians and patients experience personal uncertainty. They also indicate that the less uninformed they feel, the more both physicians and patients experience personal uncertainty.

Inverted Mucoepidermoid Papilloma and Mucous Cell Adenocarcinoma of the Palpebral Conjunctiva in Two F344 Rats

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

Bladder Cancer: Current Challenges and Future Directions

Advances in diagnosis and treatment of bladder cancer

Moving towards Personalized Medicine in Muscle-Invasive Bladder Cancer: Where Are We Now and Where Are We Going?

Advancements in Urothelial Cancer Care: Optimizing Treatment for Your Patient

Current Bladder Cancer Treatment—The Need for Improvement

Molecular pathology of urothelial carcinoma

Decisional Conflict in Patients and Their Physicians: A Dyadic Approach to Shared Decision Making

Germline Prognostic Markers for Urinary Bladder Cancer: Obstacles and Opportunities.

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Origins of Bladder Cancer

Systemic Treatment-Decision Algorithms in Muscle-Invasive Bladder Cancer: Clinical Complexities and Navigating for Improved Outcomes

Molecular Basis of Tumorigenesis of Bladder Cancer and Emerging Concepts in Developing Therapeutic Targets

Adaptive Iterative Improvement GP-based Methodology for HW/SW Co-synthesis of Embedded Systems

The importance of personalized medicine in urological cancers

Emerging molecular therapies in the treatment of bladder cancer

Disabling angina pectoris with normal coronary arteries in patients undergoing long-term hemodialysis.

Polymerase chain reaction amplification of pseudorabies virus DNA from acutely and latently infected cells.

Managing Patients with Non-Muscle Invasive Bladder Cancer: Old Disease, New Ideas